Holen Sie sich die Stockscreener-App
9.60
8.72%
0.77
Handel nachbörslich:
9.80
0.20
+2.08%
Schlusskurs vom Vortag:
$8.83
Offen:
$8.81
24-Stunden-Volumen:
891.08K
Relative Volume:
0.61
Marktkapitalisierung:
$294.48M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-29.25M
KGV:
-8.0944
EPS:
-1.186
Netto-Cashflow:
$-22.80M
1W Leistung:
+1.16%
1M Leistung:
+10.09%
6M Leistung:
+125.88%
1J Leistung:
+210.68%
1-Tages-Spanne:
$8.81
$9.825
1-Wochen-Bereich:
$8.79
$9.95
52-Wochen-Spanne:
$1.73
$10.43
Sagimet Biosciences Inc Stock (SGMT) Company Profile
Firmenname
Sagimet Biosciences Inc
Sektor
Branche
Telefon
(650) 561-8600
Adresse
155 BOVET RD., SUITE 303, SAN MATEO
Vergleichen Sie SGMT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SGMT
Sagimet Biosciences Inc
|
9.60 | 305.53M | 0 | -29.25M | -22.80M | -1.186 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Sagimet Biosciences Inc Stock (SGMT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-06 | Eingeleitet | Oppenheimer | Outperform |
| 2024-11-12 | Eingeleitet | UBS | Buy |
| 2024-06-28 | Herabstufung | Goldman | Buy → Neutral |
| 2024-05-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-03-25 | Eingeleitet | Leerink Partners | Outperform |
| 2023-08-08 | Eingeleitet | Goldman | Buy |
| 2023-08-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-08-08 | Eingeleitet | Piper Sandler | Overweight |
| 2023-08-08 | Eingeleitet | TD Cowen | Outperform |
Alle ansehen
Sagimet Biosciences Inc Aktie (SGMT) Neueste Nachrichten
What analysts say about Sagimet Biosciences Inc. stockOutstanding trading profits - jammulinksnews.com
Why Sagimet Biosciences Inc. stock attracts strong analyst attentionTargeted 200 Percent Gain - Newser
How Sagimet Biosciences Inc. stock performs during market volatilityLow Volatility High Yield Stocks - Newser
Is Sagimet Biosciences Inc. a good long term investmentOutstanding capital growth - jammulinksnews.com
What drives Sagimet Biosciences Inc. stock priceTremendous growth opportunities - jammulinksnews.com
Sagimet Biosciences Inc. Stock Analysis and ForecastOutstanding stock performance - Autocar Professional
what makes sagimet biosciences inc. stock price move sharplyShort Squeeze Radar - Newser
We Think Sagimet Biosciences (NASDAQ:SGMT) Can Afford To Drive Business Growth - Yahoo Finance
What makes Sagimet Biosciences Inc. stock price move sharplyFree Stock Market Group - Newser
Is Sagimet Biosciences, Inc. technically bullish or bearish? - MarketsMojo
Eyes on Asia: AstraZeneca, NextCure, Sagimet Biosciences - BioXconomy
Wall Street Analysts Predict a 437.05% Upside in Sagimet Biosciences Inc. (SGMT): Here's What You Should Know - MSN
Sagimet Biosciences’ SWOT analysis: promising FASN inhibitor stock faces funding hurdles By Investing.com - Investing.com South Africa
Sagimet Biosciences’ SWOT analysis: promising FASN inhibitor stock faces funding hurdles - Investing.com
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Sagimet Biosciences, Inc. Class A (SGMT) - The Globe and Mail
Sagimet stock holds steady as JMP reiterates $31 price target By Investing.com - Investing.com Nigeria
Sagimet Biosciences Inc: Analyzing SGMT Stock Trends - investchronicle.com
Sagimet Biosciences Soars 10.6% on Upgraded Price Target - AInvest
Sagimet Biosciences Plunges 11.73% Amid Acne Treatment Updates - AInvest
Two Sigma Investments LP Trims Holdings in Sagimet Biosciences Inc. (NASDAQ:SGMT) - Defense World
What Makes Sagimet Biosciences Inc. (SGMT) a Strong Momentum Stock: Buy Now? - Yahoo Finance
Sagimet Biosciences updates executive compensation By Investing.com - Investing.com South Africa
Sagimet Biosciences updates executive compensation - Investing.com
Sagimet Biosciences Elects New Directors at Annual Meeting - TipRanks
Sagimet Biosciences to Host Virtual KOL Event, “A New - GlobeNewswire
Sagimet Biosciences to host KOL event on denifanstat results - TipRanks
Sagimet Biosciences (SGMT) to Highlight Positive Phase 3 Acne Treatment Results | SGMT Stock News - GuruFocus
Sagimet Biosciences to Host Virtual KOL Event, 'A New Mechanism of Action in Treating Acne: Update on Positive Phase 3 Denifanstat Trial for the Treatment of Moderate to Severe Acne” on June 16, 2025 - The Manila Times
Sagimet Biosciences to Host Virtual KOL Event, “A New Mechanism of Action in Treating Acne: Update on Positive Phase 3 Denifanstat Trial for the Treatment of Moderate to Severe Acne” on June 16, 2025 - GlobeNewswire
Breakthrough Phase 3 Results: Novel Oral Acne Drug Shows Promise for 50M US Patients - Stock Titan
Analysts Set Sagimet Biosciences Inc. (NASDAQ:SGMT) PT at $23.17 - Defense World
Finanzdaten der Sagimet Biosciences Inc-Aktie (SGMT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):